Very low doses of rituximab in autoimmune hemolytic anemia—an open-label, phase II pilot trial - Moser, Miriam M.; Thalhammer, Renate; Sillaber, Christian; Derhaschnig, Ulla; Firbas, Christa; Jäger, Ulrich; Jilma, Bernd; Schoergenhofer, Christian (Frontiers in Medicine, 2024)